OROS hydromorphone HCl

DRUG2 trials

Sponsors

Janssen Pharmaceutica N.V., Belgium, Janssen-Cilag International NV

Conditions

Osteoarthritis, HipOsteoarthritis, KneePain

Phase 3

A Study of the Effectiveness and Safety of Sustained-release Hydromorphone (a Strong Opioid) in Patients With Chronic Noncancer Pain.

CompletedNCT00261495

Janssen Pharmaceutica N.V., BelgiumPain

Start: 2006-03-31End: 2008-04-30Updated: 2014-06-03

Placebo-controlled Trial With OROS Hydromorphone Hydrochloride to Treat Patients With Moderate to Severe Pain Induced by Osteoarthritis of the Hip or the Knee

CompletedNCT00980798

Janssen-Cilag International NVOsteoarthritis, Hip, Osteoarthritis, Knee, Pain

Start: 2007-10-31End: 2008-11-30Updated: 2014-04-25